High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$251K
$251,411
Total Sells (Filtered)
$0
$0
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
LENZ
P
LENZ Therapeutics, Inc.
Schimmelpennink Evert B.
• CEO
Discretionary BuyΔOwn +57.1%
2026-03-27
$251,411
|
||||||
| LENZ |
LENZ Therapeutics, Inc.
|
CEO
Discretionary BuyΔOwn +57.1%
|
2026-03-27 | $251,411 | P | Form 4 |